Clinical trials: Chidamide, open to volunteers
HIV-1 Infection
Clinical Research on the Use of Immune Checkpoint Inhibitors Combined With Chidamide for the Functional Cure of AIDS
Evaluate the efficacy and safety of immune checkpoint inhibitors combined with chidamide as an "activate and kill" strategy to extend viral rebound time, reduce the HIV reservoir, and achieve functional cure.
- Trial name
- NCT06902038
- Testing
- PD-1 inhibitor, Sidarbenamide
- Volunteers
- 33 people, healthy volunteers welcome
- Sponsor
- Jun Chen, MD